Akineto-rigid vs. tremor syndromes in Parkinsonism

Current Opinion in Neurology

Volumn 22, Issue 4, 2009, Pages 387-393

  Zaidel, Adam ^a,b   Arkadir, David ^c   Israel, Zvi ^d   Bergman, Hagai ^a,b,d  

^a ISR   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c Department of Neurology ^*  (Israel)

^d HEBREW UNIVERSITY   (Israel)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Basal ganglia; Oscillations; Parkinson's disease; Synchronization

Indexed keywords

DOPAMINE;

AKINESIA; BASAL GANGLION; BETA RHYTHM; CLINICAL FEATURE; CORRELATION ANALYSIS; DEPLETION; HUMAN; MUSCLE RIGIDITY; NERVE CELL NECROSIS; NERVE CONDUCTION; NONHUMAN; OSCILLATION; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; REVIEW; SUBTHALAMIC NUCLEUS; TREMOR;

ANIMALS; BASAL GANGLIA; HUMANS; PARKINSON DISEASE; TREMOR;

EID: 68449104189     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32832d9d67     Document Type: Review

References (63)

1. Haber SN. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 2003; 26:317-330.
2. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12:366-375.
3. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990; 13:281-285.
4. Gerfen CR, Engber TM, Mahan LC, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990; 250:1429-1432.
5. Surmeier DJ, Ding J, Day M, et al. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007; 30:228-235.
6. Gertler TS, Chan CS, Surmeier DJ. Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci 2008; 28:10814-10824.
7. Nambu A, Tokuno H, Takada M. Functional significance of the corticosubthalamo-pallidal 'hyperdirect' pathway. Neurosci Res 2002; 43:111-117.
8. Tachibana Y, Kita H, Chiken S, et al. Motor cortical control of internal pallidal activity through glutamatergic and GABAergic inputs in awake monkeys. Eur J Neurosci 2008; 27:238-253.
9. Levesque M, Parent A. The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proc Natl Acad Sci U S A 2005; 102:11888-11893.
10. Nadjar A, Brotchie JM, Guigoni C, et al. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia. J Neurosci 2006; 26:8653-8661.
11. Bolam JP, Hanley JJ, Booth PA, Bevan MD. Synaptic organisation of the basal ganglia. J Anat 2000; 196 (Pt 4):527-542.
12. Kita H, Kita T. Number, origins, and chemical types of rat pallidostriatal projection neurons. J Comp Neurol 2001; 437:438-448.
13. Hazrati LN, Parent A, Mitchell S, Haber SN. Evidence for interconnections between the two segments of the globus pallidus in primates: a PHA-L anterograde tracing study. Brain Res 1990; 533:171-175.
14. Sato F, Lavallee P, Levesque M, Parent A. Single-axon tracing study of neurons of the external segment of the globus pallidus in primate. J Comp Neurol 2000; 417:17-31.
15. Kita H. Neostriatal and globus pallidus stimulation induced inhibitory post-synaptic potentials in entopeduncular neurons in rat brain slice preparations. Neuroscience 2001; 105:871-879.
16. Kita H. Globus pallidus external segment. Prog Brain Res 2007; 160:111-133.
17. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997; 275:1593-1599.
18. Wickens JR. Synaptic plasticity in the basal ganglia. Behav Brain Res 2008;12;199:119-128.
19. Arbuthnott GW, Wickens J. Space, time and dopamine. Trends Neurosci 2007; 30:62-69.
20. Shen W, Flajolet M, Greengard P, Surmeier DJ. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008; 321:848-851.
21. Day M, Wokosin D, Plotkin JL, et al. Differential excitability and modulation of striatal medium spiny neuron dendrites. J Neurosci 2008; 28:11603-11614.
22. Centonze D, Gubellini P, Pisani A, et al. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev Neurosci 2003; 14:207-216.
23. Calabresi P, Di FM. ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? Neuron 2008; 60:4-7.
24. Morris G, Arkadir D, Nevet A, et al. Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 2004; 43:133-143.
25. Joshua M, Adler A, Mitelman R, et al. Midbrain dopaminergic neurons and striatal cholinergic interneurons encode the difference between reward and aversive events at different epochs of probabilistic classical conditioning trials. J Neurosci 2008; 28:11673-11684.
26. Parent A, Cote PY, Lavoie B. Chemical anatomy of primate basal ganglia. Prog Neurobiol 1995; 46:131-197.
27. Doya K. Modulators of decision making. Nat Neurosci 2008; 11:410-416.
28. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996; 334:71-76.
29. Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones; 1817.
30. Stochl J, Boomsma A, Ruzicka E, et al. On the structure of motor symptoms of Parkinson's disease. Mov Disord 2008; 23:1307-1312.
31. Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991; 50:743-755.
32. Narabayashi H, Maeda T, Yokochi F. Long-term follow-up study of nucleus ventralis intermedius and ventrolateralis thalamotomy using a microelectrode technique in parkinsonism. Appl Neurophysiol 1987; 50:330-337.
33. Lenz FA, Normand SL, Kwan HC, et al. Statistical prediction of the optimal site for thalamotomy in parkinsonian tremor. Mov Disord 1995; 10:318-328.
34. Papavassiliou E, Rau G, Heath S, et al. Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery 2008; 62 (Suppl 2):884-894.
35. Timmermann L, Florin E, Reck C. Pathological cerebral oscillatory activity in Parkinson's disease: a critical review on methods, data and hypotheses. Expert Rev Med Devices 2007; 4:651-661.
36. Poirier LJ. The development of animal models for studies in Parkinson's disease. Contemp Neurol Ser 1971; 8:83-117.
37. Poirier LJ. Experimental and histological study of midbrain dyskinesias. J Neurophysiol 1960; 23:534-551.
38. Marsden CD. Origins of normal and patholgical tremor. In: Findley LJ, Capildeo R, editors. Movement disorders: tremor. New York: Oxford University Press; 1984. pp. 37-84.
39. Burns RS, Chiueh CC, Markey SP, et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 1983; 80:4546-4550.
40. Langston JW, Forno LS, Rebert CS, Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res 1984; 292:390-394.
41. Langston JW, Irwin I, Langston EB. A comparison of the acute and chronic effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced parkinsonism in humans and the squirrel monkey. Neurology 1984; 34 (Suppl. 1): 268.
42. Pifl C, Schingnitz G, Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 1991; 44:591-605.
43. Raz A, Vaadia E, Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000; 20:8559-8571.
44. Heimer G, Bar-Gad I, Goldberg JA, Bergman H. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism. J Neurosci 2002; 22:7850-7855.
45. Rajput AH. Clinical features of tremor in extrapyramidal syndromes. In: Findley LJ, Koller WC, editors. Handbook of tremor disorders. New York: Marcel Dekker, Inc.; 1995. pp. 275-291.
46. Bergman H, Deuschl G. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord 2002; 17 (Suppl 3):S28-S40.
47. Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter MB, Jayaraman A, editors. The basal ganglia II. New York: Plenum Press; 1987. pp. 415-427.
48. Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991; 547:142-151.
49. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II: neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994; 72:507-520.
50. Filion M, Tremblay L, Bedard PJ. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991; 547:152-161.
51. Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. III: changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 1994; 72:521-530.
52. Heimer G, Rivlin-Etzion M, Bar-Gad I, et al. Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism. J Neurosci 2006; 26:8101-8114.
53. Nini A, Feingold A, Slovin H, Bergman H. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophysiol 1995; 74:1800-1805.
54. Mallet N, Pogosyan A, Marton LF, et al. Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity. J Neurosci 2008; 28:14245-14258.
55. Mallet N, Pogosyan A, Sharott A, et al. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J Neurosci 2008; 28:4795-4806.
56. Timmermann L, Gross J, Dirks M, et al. The cerebral oscillatory network of parkinsonian resting tremor. Brain 2003; 126:199-212.
57. Pollok B, Makhloufi H, Butz M, et al. Levodopa affects functional brain networks in parkinsonian resting tremor. Mov Disord 2009; 24:91-98.
58. Lemstra AW, Verhagen ML, Lee JI, et al. Tremor-frequency (3-6 Hz) activity in the sensorimotor arm representation of the internal segment of the globus pallidus in patients with Parkinson's disease. Neurosci Lett 1999; 267:129-132.
59. Hurtado JM, Rubchinsky LL, Sigvardt KA, et al. Temporal evolution of oscillations and synchrony in GPi/muscle pairs in Parkinson's disease. J Neurophysiol 2005; 93:1569-1584.
60. Lenz FA, Kwan HC, Martin RL, et al. Single unit analysis of the human ventral thalamic nuclear group. Tremor-related activity in functionally identified cells. Brain 1994; 117:531-543.
61. Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007; 30:357-364.
62. Kuhn AA, Tsui A, Aziz T, et al. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol 2009; 215:380-387.
63. Eusebio A, Chen CC, Lu CS, et al. Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson's disease. Exp Neurol 2008; 209:125-130.